|
HEADQUARTERS
HOTEL AND CONGRESS VENUE
The Hyatt Regency Washington on Capitol
Hill in Washington, DC, USA is the venue for the 2nd International Congress on
Heart Disease - New Trends in Research, Diagnosis and Treatment.
400 New Jersey Avenue, NW
Washington, DC, 2001
USA
Tel: +1 202 737 1234
Fax: +1 202 942 1576
LANGUAGE
The official language of the congress is English.
REGISTRATION
DESK
The registration desk will operate as follows:
Saturday, July 21, 2001 16:00 - 20:00 hours
Sunday, July 22, ţ2001 08:00 - 18:00 hours
Monday, July 23, 2001 08:00 - 18:00 hours
Tuesday, July 24, 2001 08:00 - 13:00 hours
PROJECTION
EQUIPMENT
A projection area will be available every day, 30 minutes
prior to the sessions, at the Hyatt Regency Washington on Capitol Hill, to
enable participants to check their slides prior to presentation. Please remember
to collect the slides from the projectionist immediately after the session.
POWER
POINT PRESENTATIONS
Equipment is available for power point presentations.
Participants wishing to use a power point presentation must come to the session
hall during the break, at least 30 minutes prior to the start of their session.
POSTER
PRESENTATIONS
Please see the program for the exact date and board number for
poster presentations. Presenters in the morning session must put up their
posters by 08:30 hours of the relevant morning and remove them at the end of the
morning sessions at 12:30 hours.
Presenters in the afternoon session must put up their posters by 14:00 hours and
remove them by 18:00 hours.
PLEASE NOTE: The congress organizer is not responsible for posters that have not
been removed / collected by the end of designated sessions.
EXHIBITION
An exhibition will take place during the congress and will be
open as follows:
Saturday, July 21, 2001 18:30 - 20:00 hours
Sunday, July 22, ţ2001 10:00 - 17:00 hours
Monday, July 23, 2001 10:00 - 17:00 hours
Tuesday, July 24, 2001 10:00 - 13:00 hours
ATTENDANCE
CERTIFICATES
An attendance certificate will be provided upon request for
participants who need proof of attendance for income tax or other purposes.
INSURANCE
The Congress Secretariat and Organizers cannot accept
liability for personal accidents or loss of or damage to private property of
participants, students and accompanying persons, either during or indirectly
arising from the 2nd International Congress on Heart Disease - New Trends in
Research, Diagnosis and Treatment. Participants should make their own
arrangements with respect to health and travel insurance.
CONGRESS
SECRETARIAT:
INTERNATIONAL CONGRESS OF HEART DISEASE
PO Box 17659, Beverly Hills, CA 90209, USA
Tel: +1 310 657 8777
Fax: +1 310 275 8922
E-mail: klimedco@ucla.edu
Website: http://www.CardiologyOnline.com
ORGANIZER:
INTERNATIONAL ACADEMIC COMMUNICATIONS
PO Box 17659, Beverly Hills, CA 90209, USA
Tel: +1 310 657 8777
Fax: +1 310 275 8922
E-mail: klimedco@ucla.edu
Website: http://www.CardiologyOnline.com
SOCIAL PROGRAM
SATURDAY, JULY 21, 2001
18:30 - 20:00 Get-Together Reception at the Exhibition Area of the Hyatt
Regency Washington on Capitol Hill.
| MONDAY, JULY
23, 2001 |
| 20:00 |
Farewell Dinner (optional)
Tickets for the Farewell Dinner may be purchased at the Registration Desk
for US$70 per person, no later than Sunday, July 22, 2001 until noon.
Please note the number of seats are limited and will be sold on a
"first come first served" basis. |
LIST OF
EXHIBITORS
CARDIACASSIST, INC
240 Alpha Drive
Pittsburgh, PA, 15238, USA
Tel: +1 412 963 7770; Fax: +1 412 963 0800
E-mail: amaihoef@cardiacassist.com
Website: www.cardiacassist.com
Revolutionary percutaneous transseptal ventricular
assist system currently under investigational device exemption.
CARDIODYNAMICS INTERNATIONAL CORP.
6175 Nancy Ridge Drive
San Diego, CA, 92121, USA
Tel: +1 858 535 0202 x 1063; Fax: +1 858 535 9622
E-mail: jconklin@cardiodynamics.com
Website: www.cardiodynamics.com
The BioZ.com® from CardioDynamics International
Corporation, is a noninvasive hemodynamic monitor that utilizes clinically
proven Impedance Cardiography (ICG) technology. The BioZ.com measures,
calculates, and continuously provides twelve hemodynamic parameters, including
cardiac output, systemic vascular resistance, contractility, and fluid status,
through the use of dual sensors placed on each side of a patient's neck and
chest.
EASTERN MEDICAL PUBLISHERS
510 Interchange Boulevard
Newark, DE, USA
Tel: +1 302 286 6020; Fax: +1 302 286 6025
E-mail: diane@empbooks.com
Website: www.empbooks.com
Eastern Medical Publishers offers the most recent
up-to-date clinical reference publications of books, journals, and CD-Roms
published by a broad range of medical publishers.
MCGRAW-HILL / APPLETON & LANGE
Medical Publishing Division
Two Penn Plaza
New York, NY 10121-2298, USA
Tel: +1 212 904 6072; Fax: +1 212 904 6030
E-mail: marissa_tavantana@mcgraw-hill.com
Website: www.mcgraw-hill.com
McGraw-Hill features new titles:
Braunwald et al: HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 15/e
Fuster et al: HURST'S THE HEART, 10/E
O'Rourke et al: HURST'S THE HEART, 10/E COMPANION HANDBOOK
Tierney et al: CURRENT MEDICAL DIAGNOSIS & TREATMENT 2001
Don Michael: MASTERING AUSCULATION CD-ROM
Ferry: BASIC ELECTROCARDIOGRAPHY IN TEN DAYS
Thompson: EXERCISE AND SPORTS CARDIOLOGY
And much more!
NOVOSTE CORPORATION
3890 Steve Reynolds Boulevard
Norcross, GA, 30093, USA
Tel: +1 770 810 3206; Fax: +1 770 925 7110
E-mail: afleshner@novoste.com
Website: www.novoste.com
Novoste™ is a world leader in the emerging field of
vascular brachytherapy. The Noveste BETA-CATH™ System is a proprietary
catheter-based delivery system, which delivers localized beta radiation to the
artery at the site of the angioplasty induced-trauma to inhibit cell
proliferation and vascular remodeling, each causes of restenosis.
VASOMEDICAL, INC
180 Linden Avenue
Westbury NY 11590, USA
Tel: +1 516 997 4600 x 115; Fax: +1 413 556 2459
E-mail: lekaireb@vasomedical.com
Website: www.vasomedical.com
Vasomedical, Inc. manufactures and distributes EECP®
external counterpulsation systems for the noninvasive treatment of intractable
angina. EECP® therapy improves perfusion within ischemic areas of the
myocardium by promoting the development of collateral circulation. For most
patients, short-term and long-term benefits include reduced anginal pain,
increased functional ability, and improved quality of life.
| 
